Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Shares Outstanding (Weighted Average): 2017-2024

Historic Shares Outstanding (Weighted Average) for Dianthus Therapeutics (DNTH) over the last 8 years, with Dec 2024 value amounting to $29.6 million.

  • Dianthus Therapeutics' Shares Outstanding (Weighted Average) rose 9.65% to $32.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.2 million, marking a year-over-year increase of 9.65%. This contributed to the annual value of $29.6 million for FY2024, which is 99.74% up from last year.
  • Latest data reveals that Dianthus Therapeutics reported Shares Outstanding (Weighted Average) of $29.6 million as of FY2024, which was up 99.74% from $14.8 million recorded in FY2023.
  • Over the past 5 years, Dianthus Therapeutics' Shares Outstanding (Weighted Average) peaked at $29.6 million during FY2024, and registered a low of $3.0 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $14.8 million (2023), whereas its average is $16.1 million.
  • Data for Dianthus Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 291.52% (in 2023) over the last 5 years.
  • Dianthus Therapeutics' Shares Outstanding (Weighted Average) (Yearly) stood at $3.0 million in 2020, then grew by 21.68% to $3.7 million in 2021, then rose by 3.03% to $3.8 million in 2022, then surged by 291.52% to $14.8 million in 2023, then skyrocketed by 99.74% to $29.6 million in 2024.